Neratinib-d6
CAS: 1259519-18-0
Ref. 3D-JAC51918
| 5mg | 1,402.00 € | ||
| 10mg | 2,242.00 € | ||
| 25mg | 4,204.00 € | ||
| 50mg | 6,726.00 € |
Product Information
Neratinib-d6 is a potent inhibitor of cancer cell growth and is used in the treatment of various types of cancer. It induces apoptosis, or programmed cell death, in cancer cells by inhibiting specific proteins that are required for their survival. This anticancer drug has been shown to be effective against a variety of tumors and is being studied for its potential use in treating other types of cancer as well. Neratinib-d6 is a medicinal inhibitor that works by blocking the action of certain enzymes involved in the cell cycle, such as Chinese hamster ovary kinase and human epidermal growth factor receptor 2 (HER2). It is also an analog of neratinib, which is another anticancer drug that has been approved for use in humans. Neratinib-d6 can be detected in urine samples, making it useful for monitoring patients undergoing treatment with this drug.
Chemical properties
Technical inquiry about: 3D-JAC51918 Neratinib-d6
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
